Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumors.AuthorsHeath, Elisabeth I.; Weise, Amy; Vaishampayan, Ulka; Danforth, Dailan; Ungerleider, Richard S.; Urata, YasuoPublicationInvestigational New Drugs, 2022, Vol 40, Issue 2, p300ISSN0167-6997Publication typeArticleDOI10.1007/s10637-021-01180-9